François E.
- Country
- Belgium
- Department
- Kinderneurologie
Research Overview
- Long-Term Safety, Tolerability, and Efficacy of Iduronate-2-Sulfatase-Fc Polypeptide in Mucopolysaccharidosis Type II Patients from DNLI-E-0002/0007 Studies
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of ALXN1850 in Adolescents and Adults with Hypophosphatasia Naïve to Asfotase Alfa Treatment
- Efficacy and Safety Evaluation of Iduronate-2-Sulfatase-Fc Polypeptide vs Idursulfase in Pediatric Mucopolysaccharidosis Type II
Data & Insights
Has run more than one trial at 10 of 45 partner sites.
Specializations
Lysosomal Storage Disorders
The investigator specializes in treating rare genetic conditions affecting the lysosomal system, with particular focus on Metachromatic Leukodystrophy (MLD) and Fabry disease. Their research encompasses innovative therapeutic approaches for these metabolic disorders.
- Late infantile MLD management
- Intrathecal treatment administration
- Enzyme replacement therapy
Their work involves evaluating novel treatment modalities for patients with enzyme deficiencies affecting the nervous system and other vital organs.
Mucopolysaccharidosis
The investigator focuses on advancing treatments for Mucopolysaccharidosis Type II (MPS II), exploring both neuronopathic and non-neuronopathic manifestations. Their research emphasizes central nervous system therapeutic approaches.
- CNS-directed therapies
- Long-term treatment outcomes
- Pediatric and young adult interventions
Their expertise extends to evaluating innovative treatments targeting both systemic and neurological manifestations of MPS II.
Metabolic Bone Disorders
The investigator conducts research in rare metabolic bone conditions, particularly Hypophosphatasia (HPP). Their work focuses on evaluating novel therapeutic approaches for previously untreated patients with this rare genetic disorder.
- Functional outcome assessment
- Adolescent and adult treatment protocols
- Novel therapeutic evaluation
Their research aims to advance treatment options for patients with genetic disorders affecting bone metabolism and development.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.